MERCK & CO., INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 131.2 USD | +0.37% |
|
+4.31% | +20.34% |
| 04-26 | Wolfe Research Adjusts Price Target on Merck & Company to $151 From $141 | MT |
| 04-26 | Morgan Stanley Adjusts Merck & Co.'s Price Target to $132 From $128 | MT |
Chart calendar Merck & Co., Inc.
2.4HQE36pvyS-22GRWvNEkY_rnIzZ8vZmKk-kPfXv4NIk.0wV0lMkl8U3lszsC859IVZurFlU388zY6a85RCOURaTRBD2Q4ljwQ_qeCw~92f8cb85f617cbbc832fef8890219d30
Upcoming events on Merck & Co., Inc.
Past events on Merck & Co., Inc.
| 25/04/2024 14:00 | Q1 2024 Earnings Call |
| 25/04/2024 11:30 | Q1 2024 Earnings Release |
| 13/03/2024 | Ex-dividend day |
| 12/03/2024 19:05 | Barclays Global Healthcare Conference |
| 11/03/2024 16:40 | Leerink Partners Global Biopharma Conference |
| 05/03/2024 18:30 | TD Cowen Health Care Conference |
| 01/02/2024 14:00 | Q4 2023 Earnings Call |
| 01/02/2024 11:30 | Q4 2023 Earnings Release |
| 25/01/2024 | American Society of Clinical Oncology Genitourinary Cancers Symposium - Abstract No : #LBA531 |
| 09/01/2024 00:30 | JPMorgan Healthcare Conference |
| 04/01/2024 17:45 | Goldman Sachs Healthcare C-Suite Unscripted Conference |
| 13/12/2023 | Ex-dividend day |
| 06/12/2023 | European Society for Medical Oncology Immuno Oncology Congress - Abstract No:121P |
| 30/11/2023 18:20 | Evercore ISI HealthCONx Conference |
| 16/11/2023 10:00 | Jefferies London Healthcare Conference |
| 08/11/2023 17:00 | UBS BioPharma Conference |
| 26/10/2023 14:00 | Q3 2023 Earnings Call |
| 26/10/2023 11:30 | Q3 2023 Earnings Release |
| 22/10/2023 18:00 | European Society for Medical Oncology Congress |
| 20/10/2023 15:15 | European Society for Medical Oncology Congress - Abstract No. - #LBA38 |
Past dividends on Merck & Co., Inc.
| 13/03/2024 | Quarterly 0.77 USD |
| 13/12/2023 | Quarterly 0.77 USD |
| 13/09/2023 | Quarterly 0.73 USD |
| 13/06/2023 | Quarterly 0.73 USD |
| 13/03/2023 | Quarterly 0.73 USD |
| 13/12/2022 | Quarterly 0.73 USD |
| 13/09/2022 | Quarterly 0.69 USD |
| 13/06/2022 | Quarterly 0.69 USD |
| 13/03/2022 | Quarterly 0.69 USD |
| 13/12/2021 | Quarterly 0.69 USD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 46 840 46 818 0.05% | 47 994 48 177 -0.38% | 48 704 48 367 0.7% | 59 283 59 144 0.24% | 60 115 59 938 0.3% | 64 047 |
|
EBITDA Million USD | Released Forecast Spread | 19 572 18 761 4.32% | 20 570 19 815 3.81% | 20 910 19 760 5.82% | 26 431 24 588 7.5% | 10 083 9 362 7.71% | 29 506 |
|
EBIT Million USD | Released Forecast Spread | 15 920 16 276 -2.19% | 16 945 17 366 -2.43% | 17 696 17 554 0.81% | 22 522 22 363 0.71% | 6 211 6 066 2.4% | 26 175 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 11 464 12 277 -6.62% | 8 791 14 906 -41.02% | 13 879 12 048 15.2% | 16 444 17 389 -5.44% | 1 889 2 857 -33.89% | 24 683 |
|
Net income Million USD | Released Forecast Spread | 9 843 9 957 -1.15% | 7 067 12 094 -41.57% | 13 049 11 797 10.61% | 14 519 14 827 -2.07% | 365 1 682 -78.3% | 19 442 |
|
EPS USD | Released Forecast Spread | 3,81 3,83 -0.52% | 2,78 4,71 -41% | 5,14 4,70 9.39% | 5,71 5,87 -2.73% | 0,14 0,56 -75.16% | 7,74 |
| Announcement Date | 05/02/20 | 04/02/21 | 03/02/22 | 02/02/23 | 01/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 13 521 13 212 2.34% | 15 901 14 648 8.55% | 14 593 13 861 5.28% | 14 959 14 043 6.52% | 13 830 13 676 1.12% | 14 487 13 799 4.98% | 15 035 14 450 4.05% | 15 962 15 273 4.51% | 14 630 14 480 1.03% | 15 775 15 204 3.75% | 15 833 | 16 668 | 15 968 | 16 565 |
|
EBITDA Million USD | Released Forecast Spread | 5 670 4 892 15.91% | 7 568 5 918 27.88% | 6 649 6 064 9.65% | 6 516 6 275 3.85% | 5 698 5 183 9.94% | 5 402 5 058 6.8% | -3 485 -3 901 10.67% | 7 538 6 724 12.1% | 665 1 985 -66.49% | 6 562 | 7 353 | 8 225 | 7 640 | |
|
EBIT Million USD | Released Forecast Spread | 4 835 4 528 6.79% | 6 448 5 393 19.56% | 5 711 5 157 10.75% | 5 557 5 268 5.49% | 4 806 4 592 4.66% | 4 411 4 088 7.89% | -4 388 -4 683 6.29% | 6 524 5 967 9.33% | -299 -476 37.23% | 6 383 5 808 9.91% | 6 520 | 7 057 | 6 305 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 3 583 3 956 -9.43% | 3 513 3 391 3.6% | 3 650 4 190 -12.89% | -5 335 -4 682 -13.95% | 5 620 5 023 11.89% | -2 046 -1 249 -63.78% | 5 670 5 267 7.66% | 6 295 | 6 724 | 5 879 | ||||
|
Net income Million USD | Released Forecast Spread | 3 758 3 557 5.64% | 4 310 3 768 14.4% | 3 944 3 859 2.19% | 3 248 3 477 -6.6% | 3 017 3 016 0.02% | 2 821 3 133 -9.97% | -5 975 -6 154 2.9% | 4 745 4 224 12.34% | -1 226 -919 -33.43% | 4 762 4 414 7.88% | 4 955 | 5 491 | 4 817 | |
|
EPS USD | Released Forecast Spread | 1,48 1,35 9.77% | 1,70 1,48 14.96% | 1,55 1,48 4.46% | 1,28 1,42 -10.11% | 1,18 1,20 -1.99% | 1,11 1,21 -8.14% | -2,35 -2,44 3.61% | 1,86 1,65 12.59% | -0,48 -0,35 -37.91% | 1,87 1,79 4.45% | 1,94 | 2,13 | 1,95 | |
| Announcement Date | 03/02/22 | 28/04/22 | 28/07/22 | 27/10/22 | 02/02/23 | 27/04/23 | 01/08/23 | 26/10/23 | 01/02/24 | 25/04/24 | - | - | - | - |
More events
Past sector events for Merck & Co., Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MRK Stock
- Calendar Merck & Co., Inc.
